Figures
Abstract
Keratins (K) are important for epithelial stress protection as evidenced by keratin mutations predisposing to human liver diseases and possibly inflammatory bowel diseases. A role for K8 in the colon is supported by the ulcerative colitis-phenotype with epithelial hyperproliferation and abnormal ion transport in K8-knockout (K8−/−) mice. The heterozygote knockout (K8+/−) colon appears normal but displays a partial ion transport-defect. Characterizing the colonic phenotype we show that K8+/− colon expresses ~50% less keratins compared to K8 wild type (K8+/+) but de novo K7 expression is observed in the top-most cells of the K8+/− and K8−/− crypts. The K8+/− colonic crypts are significantly longer due to increased epithelial hyperproliferation, but display no defects in apoptosis or inflammation in contrast to K8−/−. When exposed to colitis using the dextran sulphate sodium-model, K8+/− mice showed higher disease sensitivity and delayed recovery compared to K8+/+ littermates. Therefore, the K8+/− mild colonic phenotype correlates with decreased keratin levels and increased sensitivity to experimental colitis, suggesting that a sufficient amount of keratin is needed for efficient stress protection in the colonic epithelia.
Citation: Asghar MN, Silvander JSG, Helenius TO, Lähdeniemi IAK, Alam C, Fortelius LE, et al. (2015) The Amount of Keratins Matters for Stress Protection of the Colonic Epithelium. PLoS ONE 10(5): e0127436. https://doi.org/10.1371/journal.pone.0127436
Academic Editor: Pavel Strnad, RWTH Aachen, GERMANY
Received: January 8, 2015; Accepted: April 15, 2015; Published: May 22, 2015
Copyright: © 2015 Asghar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This work was supported by funding from the Academy of Finland #140759/126161 and 266582 to DMT, http://www.aka.fi/en-GB/A/; Sigrid Juselius Foundation to DMT, http://www.sigridjuselius.fi/foundation/contact-info/; Liv och Hälsa foundation to DMT, http://www.livochhalsa.fi/; European Union Framework 7 International Reintegration Grant to DMT, http://ec.europa.eu/research/mariecurieactions/about-mca/actions/cig/index_en.htm; The Finnish Diabetes Research Foundation to DMT, http://www.diabetestutkimus.fi/en; Åbo Akademi University Center of Excellence on Cell Stress and Molecular Aging to DMT, http://www.abo.fi/fakultet/en/Content/Document/document/26585; Turku Doctoral Programme for Biomedical Sciences to MNA, http://www.tubs.utu.fi/; Åbo Akademi University Doctoral Network in Molecular Biosciences to ISKL and JSGS, http://www.abo.fi/forskning/doctoralnetworkmolecularbiosciences; Swedish Cultural foundation to IAKL, http://www.kulturfonden.fi/en/; Finnish Cultural Foundation to CA, https://www.skr.fi/en; and Victoriastiftelsen-foundation to TOH, http://victoriastiftelsen.fi/start/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Keratins (K) are intermediate filament (IF) proteins expressed in epithelial cells. In the simple-type epithelial of the small intestine and colon, type II keratins (K7 and K8) form filaments with type I keratins (K18, K19, K20, K23) as obligate heteropolymers [1, 2]. Keratins play important roles in mechanical integrity, cell signaling, and in protection against stress [3–6]. This is evidenced by keratin mutations that cause skin disease or predispose to liver disease in humans, and multiple similar disease associations have been reported by keratin mutations in mouse models [7, 8] (www.interfil.org). During various types of stress, resident keratins and de novo keratins are upregulated on both mRNA and protein level [5]. Upregulation of simple epithelial keratins has been shown, for example after griseofulvin-induced injury in mouse liver [9], caerulein- and choline/methionine-deficient diet injuries in pancreas [10] and high-fat lithogenic diet induced gallbladder injury [11]. Stress is also often accompanied with increased keratin phosphorylation and other post-translational modifications [3, 12, 13] and in patients with liver cirrhosis, increased keratin phosphorylation correlates to disease [14].
The role of keratins in the intestine is poorly understood although they are emerging as important players in colonic function [15]. However, K8 knockout (K8-/-) mice develop an early Th2-type colitis [16] including epithelial hyperproliferation [17] and decreased apoptosis [18]. This phenotype resembles the human inflammatory bowel disease (IBD) ulcerative colitis and is similarly amendable to antibiotic treatment indicating an involvement of luminal microbiota [18]. Though keratin mutations have also been reported in some IBD patients, keratin mutations have not been clearly confirmed to predispose humans to IBD [2, 8, 19]. On molecular level, the K8-/- mouse distal colon has mistargeted and altered levels of membrane proteins and ion transporters [20, 21] which leads to a decreased short circuit current, increased net sodium absorption, decreased chloride secretion and diarrhea [21]. Genetic background effects are likely to be involved in some of the keratin murine phenotypes [22], since 94% of K8-/- mice in the C57B1/6 genetic background strain die in utero while in the FVB/n background 50% of mice escape this embryo lethality and develop the IBD-phenotype [23].
The K8-null heterozygote (K8+/-) mouse colon appears histologically normal with no apparent inflammation, but the sodium and chloride transport is disturbed, albeit not to the same extent as in the K8-/- [21]. This intermediate phenotype in the K8+/- mice led us to hypothesize that the amount of keratins may play a role in protection against stress. In this study, we further characterize the K8+/- colonic phenotype and report that K8+/- express approximately 50% less keratins compared to K8+/+ mice leading to increased epithelial thickness and an increased susceptibility to experimental colitis.
Materials and Methods
Mice and ethics statement
K8-/-, K8+/- and K8 wild type (K8+/+) mice in the FVB/n background were generated by breeding of K8+/- mice and genotyped as previously described [17]. Animal studies were performed on sex- and age-matched littermates. All animal experiments were approved by the Animal Experimental Board in Finland (ESAVI_1197–04.10.07_2013) and conformed to the legal acts, regulations and requirements set by the European Union concerning protection of animals used for research.
Antibodies
Primary mouse antibodies used for western blotting and immunostaining were rat anti-K8 and rat anti-K19 (Troma I respectively Troma III, Hybridoma bank, Iowa, USA), mouse anti-K7 (RCK 105, Abcam, Cambridge, UK), mouse anti-K20 (IT-Ks 20.10, Progen, Frankfurt, De), rat anti-K18 (Troma II, Hybridoma bank, Iowa, USA) [24], mouse anti-tubulin (Sigma, Munich, Germany), rabbit anti-caspase-7 and anti-cleaved caspase-7 (Cell Signaling, Danvers, MA, USA), rabbit anti-MPO (Thermo Scientific, Waltham, MA, USA) and rat anti-Hsc70 (Stressgen, Victoria, Canada). The secondary antibodies used for staining were Alexa 488 or Alexa 546 anti-mouse, Alexa 488 anti-rat and Alexa 488 anti-rabbit antibodies (Invitrogen, Carlsbad, CA, USA). The secondary antibodies used for western blotting were: anti-mouse HRP (GE Healthcare, Little Chalfont, UK), anti-rabbit HRP (Cell Signaling, Danvers, MA, USA) and anti-rat HRP (GE Healthcare, Little Chalfont, UK) antibodies. Nuclei were stained with Draq5 (Cell Signaling, Danvers, MA, USA) or Dapi (Invitrogen Carlsbad, CA, USA). Antibodies used for FACS analysis were anti-CD4-FITC and anti-CD49d-PE or anti-L-selectin-PE (Immunotools, Friesoythe, Germany).
Sample collection, histology, crypt length measurement, immunofluorescence and microscopy
Mice were euthanized by CO2 inhalation and the colon was excised. The colon was divided into proximal (PC) and distal colon (DC), and further divided into 4 parts. For histology, samples were fixed in 4% paraformaldehyde (PFA), in phosphate buffer saline (PBS, pH 7.4), and subsequently stained with Hematoxylin and Eosin (H&E). Samples were fresh frozen and embedded in Optimal Cutting Temperature compound (OCT) (Sakura Finetek, Netherlands) for immunostaining, collected in RNA later (Qiagen, Limburg, Netherlands) for mRNA analysis, and collected in liquid nitrogen for protein analysis. The OCT samples were further cryosectioned (6 μm) and fixed with acetone at -20°C. Immunofluorescence staining on sections was performed using the antibodies listed above. Images were captured using a Zeiss LSM780 (Jena, Germany) and Leica TCS SP5 (Wezla, Germany) confocal microscopes. Images were compiled using Adobe Illustrator and Adobe Photoshop (San Jose, CA, USA) software. Crypt lengths in PC and DC from K8+/+, K8+/- and K8-/- mice were measured from digital photographs of H&E stained colon sections taken with a Zeiss Axiovert 200M (Jena, Germany) microscope and processed using ImageJ software (National Institutes of Health, USA). The crypt lengths are expressed as mean length ± SD, calculated based on 97–417 crypts from n = 3 animals / genotype.
SDS-Page, Western blotting and quantification
Total lysates of intestinal tissues were prepared by homogenization in sample buffer containing 0.187M Tris-HCl pH 6.8, 3% sodium dodecyl sulphate (SDS) and 5mM ethylene diamine tetra acetic acid (EDTA). Protein concentration was measured using a Pierce BCA protein assay kit (Thermo Scientific, Waltham, MA, USA) and equal amount of protein was loaded and separated by SDS polyacrylamide gel electrophoresis, transferred to a polyvinylidene fluoride membrane and immunoblotted with indicated antibodies. Proteins were visualized using Western Lightning Chemiluminescence (Perkin-Elmer, Waltham, MA, USA). Protein signals were quantified from scanned films using ImageJ (National Institutes of Health, USA) by normalizing to Hsc70.
High salt extraction and Coomassie staining
High salt extraction (HSE) was preformed according to a previously described protocol [24]. Briefly, tissue samples from PC, DC, liver and small intestine, were homogenized in Triton X100 buffer using a tissue homogenizer (TissueRuptor, Quiagen, Hilden, Germany). The samples were centrifuged and the pellet was collected. The pellets were manually homogenized in high salt buffer containing 10 mM Tris-HCl, 140 mM NaCl, 1.5 M KCl, 5 mM EDTA, 0.5% Triton X100, 1 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich, St. Louis, MO, USA) and protease inhibitor mix (Complete, Roche, Mannheim, Germany), then mixed for 30 minutes at 4°C and re-pelleted. The pellets were washed in 5 mM EDTA/PBS buffer by manual homogenization, centrifuged to pellet, then re-suspended in Laemmli sample buffer. Samples were separated on a 10% acrylamide gel and stained using Coomassie Brilliant Blue.
Reverse Transcriptase-PCR
Total colon RNA was isolated from colon epithelial scrapings obtained by scraping the mucosa with a microscope slide. RNA was isolated using an RNeasy mini kit (Qiagen, Netherlands). Contaminating DNA was removed with DNase I enzymes (Promega, WI, USA) and the RNA quality was analyzed in a 1% agarose gel. 1 μg of each RNA sample was synthesized by reverse transcription to cDNA using a transcription kit (Promega, WI, USA). Target genes were amplified using specific primers (S1 Table) and KAPA probe Fast ABI Prism qPCR mix (Kapa Biosystems, MA, USA). qPCR was performed with Step One Plus Real-Time PCR system (Applied Biosystems, CA, USA). Gene expression levels were normalized to the housekeeping gene β-actin. Each cDNA was tested in triplicate and the amplification was analyzed using a 1% agarose gel.
BrdU labeling and quantification
Mice were injected by intraperitoneal (i.p.) route with 200 μl 5 mg/ml 5-bromo-2'-deoxyuridine (BrdU), BD Pharmingen, San Diego, CA, USA) in PBS, and sacrificed 4 hours after injection. Proliferative cells were stained with a BrdU detection kit (BD Pharmingen, San Diego, CA, USA) according to the manufacturer’s protocol with the modification that sections were incubated in 0.5% Borax solution (Sigma Aldrich, St. Louis, MO, USA) and 0.3% H2O2 (Sigma Aldrich, St. Louis, MO, USA) before the antigen retrieval and primary antibody incubation. The fraction of proliferative cells was quantified by counting the number of proliferative cells in relation to the total number of cells in the colonic crypts. Two mice from each genotype were quantified and 15–20 crypts / mouse were analyzed.
Ex vivo colon culture
Apoptosis of colonic tissue was measured according to the method described by [18]. Briefly, 5x5 mm colon pieces (DC and PC combined) were frozen immediately after collection (control) or incubated in cell medium (RPMI-1640 with 10% fetal calf serum (FCS), and penicillin/streptomycin) for 1 hour at 37°C to induce anoikis/apoptosis. The samples were washed with PBS immediately and stored in liquid nitrogen. The samples were homogenized and the protein concentrations were determined and further analyzed by western blotting as described above.
In vivo imaging of RONS
Reactive oxygen and nitrogen species (RONS) were detected by in vivo imaging using the luminescent probe L-012 (Wako Chemical, Neuss, Germany) as recently described [25]. Briefly, L-012 was administered at 20 mg/kg by i.p. injection to isoflurane (1.5–2.5%) anesthetized mice. The L-012 solution was prepared fresh prior to each experiment by dissolving 2 mg L-012/ml in sterile PBS protected from light. Mice were directly moved into the imaging chamber (IVIS Lumina II imaging system, Xenogen/Caliper Life Sciences, USA) and the number of photons produced by L-012 was recorded in the anesthetized mice for 30 minutes with 1 minute exposure time. The Living Image (Waltham, MA, USA) software automatically co-registers and overlays the bioluminescence images with a photographic image of the mouse.
Lamina propria cells isolation and flow cytometry
Colon lamina propria cells were isolated from K8+/+ and K8+/- mice according to a method previously described by Alam et al. [26]. In brief, colons were excised, washed in Hank’s buffered saline solution (HBSS) (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10 mM Hepes (Sigma-Aldrich, St. Louis, MO, USA), cut into 5 mm2 pieces and incubated in HBSS/Hepes buffer containing 2% FCS and 2 mM EDTA pH 8, 3 time for 15 minutes at 37°C. The colon pieces were then digested with collagenase VIII (Sigma-Aldrich, St. Louis, MO, USA), 100 U/ml in RPMI-1640 supplemented with 10 mM Hepes and 10% FCS for 1 hour, under constant stirring, at 37°C. Digested colon pieces were mixed into HBSS/Hepes buffer containing 40% Ficoll PM 400 solution (Amersham Biosciences, Little Chalfont, UK), overlaid with a 70% Ficoll gradient and centrifuged at 1950 rpm, for 20 minutes at 4°C, after which the isolated lamina propria cells were collected from the 40% / 70% Ficoll interphase and washed twice in RPMI-1640 before use. The isolated lamina propria cells were stained with indicated antibodies diluted in PBS supplemented with 2% FCS, for 30 minutes at 4°C. The cells were washed in PBS, fixed with 1% PFA and analysed using fluorescence-activated cell sorting (FACS) FACS Calibur flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) and Flowing Software 2.5 (Cell Imaging Core, Turku Centre for Biotechnology, Turku, Finland).
Dextran sulphate sodium colitis
Experimental colitis was induced in K8+/+ and K8+/- mice by giving 2% or 5% dextran sulphate sodium (DSS; TdB consultancy, Uppsala Sweden; 40 000 Da) in autoclaved drinking water for 7 days, followed by autoclaved water for 4 or 2 additional days for the 2% and 5% DSS experiment, respectively. In a different experiment, 3% DSS was administered in the drinking water for 5 days, followed by autoclaved drinking water for 7 days. The 5% DSS treatment lead to the most severe disease and in some mice lethality. In all DSS experiments, to ensure humane treatment, mice were observed 1–3 times per day (during days 1–7) and for the 5% DSS experiment 3 times per day, then with 6–8 hour intervals during days 8 to 10 to monitor mouse weight and overall health. Mice were sacrificed by CO2 inhalation if their body weight was reduced below 20% of the body weight at the start of the experiment according to the approved protocol. Mice that died suddenly between monitoring hours (but had lost less than 20% body weight) and mice that were moribund and sacrificed due to 20% loss of body weight were considered dead in the survival analysis. Mouse appearance such as fur condition and mobility in the cage were also monitored, and it was ensured that mice had access to water and food. No analgesics were used in the study. For the chronic DSS experiment, mice were administered 2.5% DSS for 7 days, followed by autoclaved water for 14 days, then a second round of 2.5% DSS for 7 days, followed by normal water until mice were sacrificed 7 or 17 days after the second DSS administration. Control mice were given normal water throughout the experiment. Day 1 denotes the baseline situation and when DSS-treatment was started. Drinking bottles were replaced with fresh DSS solution on day 3 and 5. Mice were weighed, observed for blood and loose stools daily or on indicated time points during the experiment [27]. The colitis score from H&E-stained samples was determined by two scientists in a blinded fashion according to the method reported [28]. The severity of the diarrhea was assessed by scoring stool consistency using the following key: solid = 1, soft = 2, slightly watery = 3, and watery = 4. Rectal bleeding was scored using the following key: none = 0, traces of blood = 1, blood mixed-stool = 2, congealed blood around rectal areas = 3, fresh bleeding at rectal areas = 4. Disease activity index (DAI) is a score where stool consistency, bleeding score and body weight loss is combined into one value determining how severely the mice are affected by colitis. The DAI was calculated as: 1 point for every 5% of body weight loss; stool consistency score is scored as: 0) for solid pellets, 1) soft pellets, 2) slightly loose and 3) liquid and the bleeding score defines the presence of blood: 1) blood found in stool pellets and 2) blood found at anus either clotted or fresh.
Statistical analysis
Statistical analysis was performed by using student t-test (% body weight change, stool hydration, colon length, occult blood score, crypt length), Mann-Whitney U test (in vivo imaging), One way Anova and Bonferroni post hoc test (mRNA, BrdU and protein levels), and Kaplan-Meier test (survival) using GraphPad Prism 5 software (La Jolla, CA, USA).
Results
Heterozygous deletion of K8 results in 50% less keratin protein and K8 mRNA in the colonic epithelium
To assess whether K8+/- mice, which have only one K8 allele, express decreased levels of keratins in the colon, western blots and RT-PCR for keratins K7, K8, K18, K19 and K20 were performed and keratin levels in K8+/- mice were compared to sex- and age-matched littermate K8+/+ and K8-/- mice (Fig 1). At the protein level, the K8+/- colon has 50% less K8 compared to the K8+/+ colon (Fig 1A and 1B). The second type II keratin, K7 and type I K18 were also significantly decreased in K8+/- colon, and to a lesser extent also K19 and K20 compared to K8+/+. RT-PCR analysis showed a similar ~50% decrease of K8 mRNA in the K8+/- colon and a complete loss in K8-/-, compared to K8+/+, while mRNA for the other keratins were unaltered (Fig 1C). High salt extraction of colonic keratins showed that K8 and K19 are the main type II and type I keratins in colon, respectively, and that no compensatory keratin protein or other major protein precipitated with high salt is increased in K8+/- and K8-/- mice (S1 Fig).
A. Total lysates of colon from K8+/+, K8+/- and K8-/- mice (n = 3) were analyzed for the amount of K8, K18, K19 and K20 using SDS-PAGE and western blotting. Equal amount of protein was loaded to each well and Hsc70 was used as loading control. B. Keratin protein expression was quantified using ImageJ software. C. RT-PCR was performed to measure keratin mRNA levels in total RNA isolated from colon scrapings. Target genes were amplified using specific primers and KAPA probe Fast ABI Prism qPCR mix. Gene expression levels were normalized to the housekeeping gene β-actin. * = P < 0.05. Results are given as means ± SEM.
The distribution of keratins in K8+/- colon is unaltered except for K7, which is expressed higher up in the K8+/- crypts
The distribution of colonic keratins was analyzed by immunofluorescence staining (Fig 2A and 2B) using specific primary antibodies for each keratin. The distribution of K8, K18, K19 and K20 were unaltered in the K8+/- colon (Fig 2A and 2B), although the decreased protein levels quantified in Fig 1 were clearly distinguishable under these carefully comparable confocal scanning settings (Fig 2A and 2B). K7 which normally is expressed mainly in the bottom part of the crypts, was however, found to be expressed in all cells throughout the crypt in the K8+/- colon (Fig 2Ba–2Bc) suggesting that K7 compensates in the absence of K8 in the cells close to the luminal region. The keratin distribution in K8+/+, K8+/- and K8-/- colon is schematically summarized in S2 Fig.
Fresh frozen sections from K8+/+, K8+/- and K8-/- mice (n = 3) were fixed with acetone and stained for A. K8, K18, K19, and B. K7, K20. The distribution of K7 in K8+/- and K8-/- crypts is extended to the top of the crypts (B: b, c) compared to K8+/+ where K8 is the only type II keratin in the top epithelial cells (area between dotted and solid line, B: a and A: a, b). Scale bar = 100 μm. L = lumen; M = muscle. Nuclei = blue. Insert in Bf. shows signal from secondary antibody alone.
K8+/- mice show a moderate colonic hyperproliferation phenotype but no spontaneous intestinal inflammation
We next examined the K8+/- colon histology to assess whether the decreased K8 expression causes histopathological changes. H&E staining showed that the crypts in K8+/- DC and PC were significantly longer (Fig 3A) compared to K8+/+, but shorter than the previously described K8-/- hyperplastic crypts (Fig 3A) [17, 21]. The average crypt length in K8+/+ and K8+/- proximal colon were 0.10 ± 0.003 mm and 0.12 ± 0.01 mm, respectively, and in K8+/+ and K8+/- distal colon 0.18 ± 0.01 mm and 0.21 ± 0.02 mm, respectively. The crypt lengths in K8-/- mice were 0.21± 0.002 mm and 0.33 ± 0.08 mm (for PC and DC, respectively; Fig 3B). To test whether the longer crypts were related to increased proliferation, mice were injected with the proliferation marker, BrdU, which marks dividing cells. The BrdU staining indicated a wider zone of proliferative cells in the K8+/- proximal and distal colon (Fig 4A) compared to K8+/+. Quantification revealed that K8+/- colon had a significantly higher percent of BrdU-positive cells/crypt, compared to K8+/+, but fewer compared to the K8-/- colon (Fig 4B). In contrast to the resistance to anoikis (apoptosis) we have described in K8-/- [18], no difference in anoikis was noticed in the K8+/- colon when assayed for cleaved caspase 7 one hour after ex vivo culture (Fig 4C).
A. The K8+/- baseline morphology was studied by H&E staining of the distal colon (DC) and proximal colon (PC) and the crypt lengths were measured (black arrows). B. Crypt lengths in PC and DC were measured from digital photographs of H&E stained colon sections (n = 3) taken with Zeiss Axiovert 200M microscope and processed using ImageJ software. The crypt lengths are expressed as mean length ± SD, calculated based on crypts from 3 animals / genotype.
A. and B. Mice were injected with BrdU (Bromodeoxyuridine, 5-bromo-2-deoxyuridine) i.p. 4 hours before sacrifice and proliferative cells were stained with anti-BrdU and quantified. Proliferating cells were significantly increased in both K8+/- and K8-/- mice DC (distal colon; A. b, c) and PC (proximal colon; A. e, f) compared to K8+/+ mice (A. a, d). Scale (a, d) = 50 μm. Brackets indicate the proliferative cell zone at the bottom of the crypt. B. The fraction of proliferative cells was quantified by counting the number of proliferative cells in relation to the total number of cells in the colonic crypts. Increased number of BrdU positive cells directly indicates the hyperproliferation in K8+/- and K8-/- colon. *** p<0.001. C. The level of apoptosis was assessed from K8+/- and K8-/- colon lysates by immunoblotting for cleaved caspase 7 (cCasp7) directly after excising from the mouse or after 1 hour of incubation at 37°C in cell culture medium. Hsc70 and caspase 7 (Casp7) were used as loading controls.
To assess whether K8+/- mice may be prone to spontaneous colitis similar to K8-/- [16, 18], the K8+/- colon was analyzed for signs of inflammation. Myeloperoxidase (MPO) is an enzyme secreted by neutrophils at the site of inflammation [29] and is widely used as a marker of murine colitis. MPO was clearly increased in the K8-/- colon (Fig 5Ac) while K8+/- MPO levels were comparable to those in K8+/+ (Fig 5Aa and 5Ab) indicating no major inflammation. To monitor oxidative stress in K8+/- mice, we used a recently established in vivo imaging method that detects RONS using the chemiluminescent probe L-012 [25, 30]. K8+/- mice showed abdominal RONS signals similar to K8+/+ mice, whereas K8-/- had high signals (Fig 5Ba and 5Bb). The RONS signals did not increase in aging K8+/- mice (Fig 4Bc). In contrast to the clear inflammatory profile of the K8-/- colon lamina propria T-cells, the K8+/- colon T-cells were very similar to those in K8+/+ colon in terms of number of T-cells (not shown), percentage of naïve (L-selectin positive) to effector T-cells (L-selectin negative) and integrin α4 expression (Fig 5Ca and 5Cb). Furthermore the colon length is similar in K8+/+ and K8+/- mice, in contrast to K8-/- mice, which have a shorter colon (S2 Table). Taken together, the decreased levels of K8 in the K8+/- mouse colon leads to an intermediate phenotype with longer crypts, but without inflammation.
A. Cryosections from K8+/+, K8+/- and K8-/- mice (n = 3) were stained for myeloperoxidase (MPO). White arrows indicate MPO positive cells. Scale bar: 100 μm; L = lumen, M = muscle. B. In vivo imaging for RONS. B.a. For in vivo imaging of inflammation, mice were injected i.p. with L-012 and luminescent signals obtained by an IVIS camera (Ba). The abdominal chemiluminescence signals were quantified and shown as average ± SD in adult mice (Bb), and young versus old mice (Bc). C. The colonic lamina propria (LP) cells were isolated from K8+/+ and K8-/- mice, stained with anti CD4-FITC and anti-CD49d-PE or anti-L-selectin-PE and further analysed using a flow cytometer.
K8+/- mice are more sensitive to DSS-induced experimental colitis
We hypothesized that the decreased levels of keratins may render K8+/- mice more susceptible to colonic stress. To test this, mice were treated with different regimens of DSS in the drinking water followed by different recovery periods to induce acute or chronic disease [27]. An acute regimen of 5% DSS for 7 days plus 2 days with DSS-free drinking water, resulted in body weight loss, moderate to severe diarrhea and rectal bleeding in both K8+/- and K8+/+ mice (Fig 6A–6C). The body weight loss was slightly but significantly greater in K8+/- mice compared to K8+/+ mice on days 6–9 (Fig 6A) and K8+/- mice had significantly more severe rectal bleeding from day 3 onwards (Fig 6B). The high dose of 5% DSS resulted in lethality after day 7 which was higher in K8+/- compared to K8+/+ mice: on day 10, 8% of K8+/- survived compared to 42% of K8+/+ mice (p < 0.05 on day 10; Fig 6C). In both K8+/+ and K8+/- mice, 5% DSS induced a significant shortening of the colon compared with healthy K8+/+ and K8+/- mice, respectively, while no difference in colon length was noted between treated K8+/+ and K8+/- mice (S2 Table).
Mice were given 5% DSS in drinking water for 7 days followed by regular water for 2 days and assessed for body weight change (A), bleeding score (B) and survival (C). (n = 12–13, p = < 0.05 on day 10). D. 3% DSS in autoclaved drinking water mice were administered up to day 5 followed by drinking water up to day 12 (D-H). *p < 0.05. F. Longitudinal sections from colon were stained with H&E staining and (G and F), and a histological score was determined. Scale bar: 100 μm.
To induce acute but less severe colitis, mice were administered 3% DSS in autoclaved drinking water for 5 days followed by autoclaved water up to day 12 (Fig 6D–6H). As expected, the 3% DSS regimen compared to 5% DSS resulted in a less dramatic body weight change which was only significantly different between K8+/- and K8+/+ on day 7 (Fig 6D). However, K8+/- mice had significantly higher stool consistency score compared to K8+/+ mice (Fig 6E; on days 3–6, 8, 12) and the DAI was significantly higher during days 3–6 between the genotypes (not shown). Histological scoring showed a higher colitis score for K8+/- than K8+/+ (Fig 6F) at the end of the experiment on day 12. In a small-scale chronic DSS experiment (two rounds of 7 days with 2.5% DSS + with a 2 week brake with autoclaved water), K8+/- mice also were more sensitive and displayed slightly worse histology, higher average DAI, more MPO-positive cells, slightly more apoptosis (S3A–S3C Fig) and shorter colon length (S2 Table) compared than K8+/+. The DSS data also suggest that K8+/- mice respond faster to DSS (Fig 6B and 6E), and recover more slowly from the DSS (Fig 6B and 6E, S3A Fig) compared to K8+/+. Taken together, K8+/- mice are more susceptible to DSS-colitis than littermate K8+/+.
Discussion
We have here characterized the pathological, immunological and stress-response phenotype of the K8+/- mouse colon where one of the two K8 alleles have been inactivated (Table 1). The hitherto reported colonic phenotype of this mouse is normal-appearing histology, but a sodium and chloride transport-defect intermediate between control K8+/+ and the nearly keratin-free K8-/- colon [17, 21]. We here show that heterozygous deletion of K8 results in a 50% decrease in K8 mRNA and K8 protein in the colonic epithelium. The remaining keratins are spatially normally distributed in the colonic crypt, except for K7 which is expressed higher up in the crypts compared to K8+/+, but not increased on overall protein level. The K8+/- mice have an intermediate colonic hyperproliferation phenotype, but in contrast to the K8-/- colon tissue [16], they lack any signs of spontaneous intestinal inflammation. K8+/- mice have, however, increased sensitivity and delayed recovery from DSS-induced experimental colitis suggesting that reduced keratin levels significantly compromise stress protection and the regenerative capacity of colonic epithelial cells.
Apart from the 50% decreased levels of K8, K8+/- colonic crypt epithelial cells contain all colonic keratins including K7, K18, K19 and K20 at normal mRNA levels, but have decreased average protein levels of all keratins and significantly decreased levels of K7 and K18. Together this data suggest that keratin mRNA are transcribed independent of K8 mRNA, while sufficient K8 mRNA and the presence of K8 as a type I keratin partner is needed for protein and filament stabilization. No other type II keratin mRNA was increased in a microarray comparison of K8+/+ and K8+/- colonic crypt scrapings (data not shown). The decreased levels of K8+/- keratins were seen both by western blotting and immunostaining, and the staining results further indicate that keratin levels are decreased evenly throughout the crypt. Interestingly, K7, which is normally expressed only at the base and middle regions of the colonic crypts, was expressed de novo higher up in the in K8+/- crypts indicating that K7 is compensating for K8 in this specific tissue compartment where K8 is normally the only type II keratin. A similar de novo K7 expression was also seen in the K8-/- colonocyte apical compartment which lacks cytoplasmic filaments altogether. Detecting K7 in this K8+/- and K8-/- cellular compartment is anticipated since type I keratins (K18, K19, K20) are present there by staining, requiring a type II keratin for protein and filament stabilization. The apical compartment of keratins is likely important for the integrity of this single layered epithelium as seen in the small intestine [20]. In the recently generated K7-/- mouse, a similar 50% decrease in K7 mRNA and protein was noted in the K7+/- bladder epithelium while the other keratin mRNAs were unaltered [31]. Interestingly, a small increase in K20 mRNA was described in the K7-/- bladder and a similar slight, but not significant, elevation is noted in the K8-/- colon. Our finding in the colon suggest that K8 levels are essential in regulating the protein levels of the other intestinal keratins, and that the clear gene dose-dependent difference in keratin protein levels, i.e. K8-/- < K8+/- < K8+/+, could be used as a controlled in vivo model to further study the effect of keratin levels in intestinal health.
Based on the above findings on decreased keratin levels in the K8+/- colon and the emerging function of IFs and keratins as important players in cytoprotection from stress [5, 6, 32, 33], we analyzed for a possible tissue proliferation, apoptosis and inflammation phenotype in these mice. Careful histological analysis revealed that the K8+/- colonic epithelium is significantly thicker than the K8+/+ mouse colonic epithelium due to increased epithelial cell proliferation, however, no decreased anoikis could be detected as in contrast to the more dramatically thickened K8-/- epithelium [18]. Such increased proliferation has not to our knowledge previously been reported for the loss of one keratin allele and e.g. the K7+/- bladder had no reported phenotype although the full knockdown of K7 bladder, similar to the K8 colon epithelia, is hyperproliferative [31]. Keratin function has been linked to proliferation/cell cycle as reviewed by Pan et al. [6] and e.g. knockdown of keratins is associated with increased proliferation in breast cell culture systems, and keratin overexpression correlates with decreased proliferation [34]. The signaling mechanisms behind how low keratin levels leads to increased proliferation needs further investigation but may involve keratin interaction with 14-3-3 or Akt signaling [6]. In contrast to the K8-/- colitis phenotype [16] no signs of inflammation were detected in the K8+/- using several different techniques. Together with the previously reported significant K8-dose dependent ion transport defect-phenotype [21], these data suggest that normal K8 levels are required to maintain intestinal homeostasis on proliferation and ion transport, while 50% of normal keratin levels are sufficient to protect from developing spontaneous colitis. Keratins can be considered stress proteins with many functions in common with the bona fide heat shock stress proteins, such as significant up regulation in response to various stresses, protein abundance, cytoprotection, and the linkage IF protein or heat shock mutations to several human diseases [5]. Our studies further support a function in stress-protection in the colon, since K8+/- mice are more sensitive when stressed with the experimental colitis model DSS. K8+/- mice also showed slower recovery from DSS suggesting an importance of keratins in both stress protection and recovery from stress. Whether the increased K8+/- proliferation is linked to colitis susceptibility is unclear and has not been comprehensively studied in other models. Interestingly, deletion of ion transporters has been linked to increased colonic epithelial proliferation [35] and this keratin-ion transport link warrants further investigation. However, knockdown of the Wnt agonist Dkk, which leads to a similar basal increased proliferation, protects mice from DSS-induced colitis and recovery [36], indicating that these pathways are complex.
While a few IBD patients with keratin mutations have been described, it is currently unclear if keratin mutations subject humans to IBD [2]. Recently, however, it has been shown that K8 and K18 mutations disrupt the barrier function in colonic cell cultures [37]. Patients with keratin mutations that predisposed to liver diseases typically develop liver disease if subjected to a second stress that specifically affects the liver, such as drugs or alcohol [2]. In this sense, the K8+/- colon with a rather mild baseline phenotype but increased susceptibility to the second stress by DSS, should serve as a good model to study keratins in the intestine without the effect of baseline colitis or overexpressing a keratin mutation, where the increased keratin levels may be protective.
Supporting Information
S1 Fig. K8 deletion does not lead to an increase of compensating proteins in the high salt cytoskeleton fraction of the colon.
https://doi.org/10.1371/journal.pone.0127436.s001
(DOCX)
S2 Fig. Schematic overview of the keratin crypt distribution as a function of full or partial K8 deletion.
https://doi.org/10.1371/journal.pone.0127436.s002
(DOCX)
S3 Fig. K8+/- mice are more sensitive to chronic 2.5% DSS treatment.
https://doi.org/10.1371/journal.pone.0127436.s003
(DOCX)
S1 Table. Forward and reverse primers used for RT-PCR.
https://doi.org/10.1371/journal.pone.0127436.s004
(DOCX)
S2 Table. Colon length measurements in untreated and DSS-treated K8+/+ and K8+/- mice.
https://doi.org/10.1371/journal.pone.0127436.s005
(DOCX)
Acknowledgments
We thank Hélène Baribault for providing the K8-/- mice, Aida Habtezion for early BrdU experiments, and Julia Misiorek and Joel Nyström for help in setting up the colon RT-PCR assays and for samples, respectively. Helena Saarento, Dareen Fteita, Erica Nyman, and the personnel at Central Animal laboratory, Turku Centre for Disease Modeling, Cell imaging core at BTK, and Åbo Akademi University biosciences technical personnel are acknowledged for skillful assistance.
Author Contributions
Conceived and designed the experiments: MNA JSGS TOH DMT. Performed the experiments: MNA JSGS LEF IAKL CA TOH ROH DMT. Analyzed the data: MNA JSGS LEF IAKL CA TOH ROH DMT. Contributed reagents/materials/analysis tools: DMT. Wrote the paper: MNA JSGS LEF IAKL CA TOH ROH DMT.
References
- 1. Ku NO, Zhou X, Toivola DM, Omary MB. The cytoskeleton of digestive epithelia in health and disease. Am J Physiol. 1999;277(6 Pt 1):G1108–37. Epub 1999/12/22. pmid:10600809.
- 2. Omary MB. "IF-pathies": a broad spectrum of intermediate filament-associated diseases. J Clin Invest. 2009;119(7):1756–62. Epub 2009/07/10. doi: 39894 [pii] pmid:19587450.
- 3. Toivola DM, Tao GZ, Habtezion A, Liao J, Omary MB. Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments. Trends Cell Biol. 2005;15(11):608–17. Epub 2005/10/06. doi: S0962-8924(05)00228-X [pii] pmid:16202602.
- 4. Pallari HM, Eriksson JE. Intermediate filaments as signaling platforms. Sci STKE. 2006;2006(366):pe53. Epub 2006/12/21. doi: stke.3662006pe53 [pii] pmid:17179489.
- 5. Toivola DM, Strnad P, Habtezion A, Omary MB. Intermediate filaments take the heat as stress proteins. Trends Cell Biol. 2010;20(2):79–91. Epub 2010/01/05. doi: S0962-8924(09)00272-4 [pii] pmid:20045331.
- 6. Pan X, Hobbs RP, Coulombe PA. The expanding significance of keratin intermediate filaments in normal and diseased epithelia. Current opinion in cell biology. 2013;25(1):47–56. Epub 2012/12/29. doi: S0955-0674(12)00182-2 [pii] pmid:23270662.
- 7. Omary MB, Ku NO, Strnad P, Hanada S. Toward unraveling the complexity of simple epithelial keratins in human disease. J Clin Invest. 2009;119(7):1794–805. Epub 2009/07/10. doi: 37762 [pii] pmid:19587454.
- 8. Toivola DM, Boor P, Alam C, Strnad P. Keratins in health and disease. Current opinion in cell biology. 2015;32C:73–81. pmid:25599598.
- 9. Cadrin M, Hovington H, Marceau N, McFarlane-Anderson N. Early perturbations in keratin and actin gene expression and fibrillar organisation in griseofulvin-fed mouse liver. J Hepatol. 2000;33(2):199–207. Epub 2000/08/22. doi: S0168-8278(00)80360-8 [pii]. pmid:10952237.
- 10. Zhong B, Omary MB. Actin overexpression parallels severity of pancreatic injury. Exp Cell Res. 2004;299(2):404–14. Epub 2004/09/08. S001448270400285X [pii]. pmid:15350539.
- 11. Tao GZ, Toivola DM, Zhong B, Michie SA, Resurreccion EZ, Tamai Y, et al. Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury. J Cell Sci. 2003;116(Pt 22):4629–38. Epub 2003/10/25. 116/22/4629 [pii]. pmid:14576356.
- 12. Omary MB, Ku NO, Tao GZ, Toivola DM, Liao J. "Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem Sci. 2006;31(7):383–94. Epub 2006/06/20. doi: S0968-0004(06)00142-3 [pii] pmid:16782342.
- 13. Snider NT, Omary MB. Post-translational modifications of intermediate filament proteins: mechanisms and functions. Nat Rev Mol Cell Biol. 2014;15(3):163–77. pmid:24556839; PubMed Central PMCID: PMC4079540.
- 14. Toivola DM, Ku NO, Resurreccion EZ, Nelson DR, Wright TL, Omary MB. Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology. 2004;40(2):459–66. Epub 2004/09/16. pmid:15368451.
- 15. Majumdar D, Tiernan JP, Lobo AJ, Evans CA, Corfe BM. Keratins in colorectal epithelial function and disease. Int J Exp Pathol. 2012;93(5):305–18. pmid:22974212; PubMed Central PMCID: PMC3444987.
- 16. Habtezion A, Toivola DM, Butcher EC, Omary MB. Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment. J Cell Sci. 2005;118(Pt 9):1971–80. Epub 2005/04/21. doi: jcs.02316 [pii] pmid:15840656.
- 17. Baribault H, Penner J, Iozzo RV, Wilson-Heiner M. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes & development. 1994;8(24):2964–73. Epub 1994/12/15. pmid:7528156.
- 18. Habtezion A, Toivola DM, Asghar MN, Kronmal GS, Brooks JD, Butcher EC, et al. Absence of keratin 8 confers a paradoxical microflora-dependent resistance to apoptosis in the colon. Proc Natl Acad Sci U S A. 2011;108(4):1445–50. Epub 2011/01/12. 1010833108 [pii] pmid:21220329.
- 19. Tao GZ, Strnad P, Zhou Q, Kamal A, Zhang L, Madani ND, et al. Analysis of keratin polypeptides 8 and 19 variants in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5(7):857–64. Epub 2007/05/19. doi: S1542-3565(07)00188-7 [pii] pmid:17509943.
- 20. Ameen NA, Figueroa Y, Salas PJ. Anomalous apical plasma membrane phenotype in CK8-deficient mice indicates a novel role for intermediate filaments in the polarization of simple epithelia. J Cell Sci. 2001;114(Pt 3):563–75. Epub 2001/02/15. pmid:11171325.
- 21. Toivola DM, Krishnan S, Binder HJ, Singh SK, Omary MB. Keratins modulate colonocyte electrolyte transport via protein mistargeting. J Cell Biol. 2004;164(6):911–21. Epub 2004/03/10. jcb.200308103 [pii]. pmid:15007064.
- 22. Haybaeck J, Stumptner C, Thueringer A, Kolbe T, Magin TM, Hesse M, et al. Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model. Laboratory investigation; a journal of technical methods and pathology. 2012;92(6):857–67. pmid:22449798.
- 23. Baribault H, Price J, Miyai K, Oshima RG. Mid-gestational lethality in mice lacking keratin 8. Genes & development. 1993;7(7A):1191–202. pmid:7686525.
- 24. Ku NO, Toivola DM, Zhou Q, Tao GZ, Zhong B, Omary MB. Studying simple epithelial keratins in cells and tissues. Methods Cell Biol. 2004;78:489–517. Epub 2005/01/14. pmid:15646629.
- 25. Asghar MN, Emani R, Alam C, Helenius TO, Gronroos TJ, Sareila O, et al. In vivo imaging of reactive oxygen and nitrogen species in murine colitis. Inflammatory bowel diseases. 2014;20(8):1435–47. pmid:24983980.
- 26. Alam C, Valkonen S, Palagani V, Jalava J, Eerola E, Hanninen A. Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change. Diabetes. 2010;59(9):2237–46. Epub 2010/06/16. doi: db10-0147 [pii] pmid:20547977.
- 27. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2(3):541–6. Epub 2007/04/05. doi: nprot.2007.41 [pii] pmid:17406617.
- 28. ten Hove T, Drillenburg P, Wijnholds J, Te Velde AA, van Deventer SJ. Differential susceptibility of multidrug resistance protein-1 deficient mice to DSS and TNBS-induced colitis. Dig Dis Sci. 2002;47(9):2056–63. Epub 2002/10/02. pmid:12353855.
- 29. Chuang SS, Li CY. Useful panel of antibodies for the classification of acute leukemia by immunohistochemical methods in bone marrow trephine biopsy specimens. Am J Clin Pathol. 1997;107(4):410–8. Epub 1997/04/01. pmid:9124209.
- 30. Kielland A, Blom T, Nandakumar KS, Holmdahl R, Blomhoff R, Carlsen H. In vivo imaging of reactive oxygen and nitrogen species in inflammation using the luminescent probe L-012. Free Radic Biol Med. 2009;47(6):760–6. Epub 2009/06/23. doi: S0891-5849(09)00363-3 [pii] pmid:19539751.
- 31. Sandilands A, Smith FJ, Lunny DP, Campbell LE, Davidson KM, MacCallum SF, et al. Generation and characterisation of keratin 7 (K7) knockout mice. PLoS One. 2013;8(5):e64404. Epub 2013/06/07. PONE-D-13-12420 [pii]. pmid:23741325.
- 32. Pekny M, Lane EB. Intermediate filaments and stress. Exp Cell Res. 2007;313(10):2244–54. Epub 2007/05/26. doi: S0014-4827(07)00168-1 [pii] pmid:17524394.
- 33. Kim S, Coulombe PA. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes & development. 2007;21(13):1581–97. Epub 2007/07/04. doi: 21/13/1581 [pii] pmid:17606637.
- 34. Iyer SV, Dange PP, Alam H, Sawant SS, Ingle AD, Borges AM, et al. Understanding the role of keratins 8 and 18 in neoplastic potential of breast cancer derived cell lines. PLoS One. 2013;8(1):e53532. pmid:23341946; PubMed Central PMCID: PMC3546083.
- 35. Schweinfest CW, Spyropoulos DD, Henderson KW, Kim JH, Chapman JM, Barone S, et al. slc26a3 (dra)-deficient mice display chloride-losing diarrhea, enhanced colonic proliferation, and distinct up-regulation of ion transporters in the colon. J Biol Chem. 2006;281(49):37962–71. pmid:17001077.
- 36. Koch S, Nava P, Addis C, Kim W, Denning TL, Li L, et al. The Wnt antagonist Dkk1 regulates intestinal epithelial homeostasis and wound repair. Gastroenterology. 2011;141(1):259–68, 68 e1-8. pmid:21440550; PubMed Central PMCID: PMC3551610.
- 37. Zupancic T, Stojan J, Lane EB, Komel R, Bedina-Zavec A, Liovic M. Intestinal cell barrier function in vitro is severely compromised by keratin 8 and 18 mutations identified in patients with inflammatory bowel disease. PLoS One. 2014;9(6):e99398. Epub 2014/06/11. PONE-D-14-10127 [pii]. pmid:24915158.